Amesite Inc
For the period ended Dec 31, 2023. Filed Feb 14, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Dec 31, 2023 · Filed Feb 14, 2024
AMST$0.48-9.4%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Statements of Cash Flows (unaudited)
| Six Months Ended | ||
|---|---|---|
| December 31, | ||
| 2023 | 2022 | |
| Cash Flows from Operating Activities | ||
| Net Loss | $(1,796,304) | $(2,276,821) |
| Adjustments to reconcile change in net loss to net cash used in operating activities: | ||
| Depreciation and amortization | 292,025 | 362,340 |
| Stock-based compensation expense | 88,232 | 97,879 |
| Value of common stock issued in exchange for consulting services | - | 71,940 |
| Changes in operating assets and liabilities which used cash: | ||
| Accounts Receivable | 15,000 | (90,440) |
| Prepaid expenses and other current assets | (87,421) | 298,860 |
| Accounts payable | (5,244) | (9,422) |
| Accrued compensation | (25,400) | (137,856) |
| Deferred revenue | (40,833) | (65,932) |
| Accrued and other liabilities | (17,887) | (87,110) |
| Net cash and cash equivalents used in operating activities | (1,577,832) | (1,836,562) |
| Cash Flows from Investing Activities | ||
| Purchase of property and equipment | (1,166) | (2,861) |
| Investment in capitalized software | (118,200) | (175,209) |
| Net cash and cash equivalents used in investing activities | (119,366) | (178,070) |
| Cash flows from Financing Activity | ||
| Issuance of common stock - net of issuance costs | - | 1,850,501 |
| Net cash and cash equivalents provided by financing activity | - | 1,850,501 |
| Net decrease in cash and cash equivalents | (1,697,198) | (164,131) |
| Cash and cash equivalents - Beginning of period | 5,360,661 | 7,155,367 |
| Cash and cash equivalents - End of period | $3,663,463 | $6,991,236 |
-6-
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.